High Dose Rate Brachytherapy in the Management of Non-Melanoma Skin Cancer (NMSC): A Retrospective Review
Skin cancer is the most common form of cancer in the United States. Research estimates that nonmelanoma skin cancer, including basal cell carcinoma and squamous cell carcinoma, affects more than 3 million Americans a year. The incidence of both non-melanoma and melanoma skin cancers has been increasing over the past decades. Fortunately, most NMSC lesions are detected at an early stage that is amenable to very effective local therapy and thus are highly curable. Various therapeutic modalities are currently being used to treat these tumors, including surgery, topical treatments and radiotherapy.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Beatriz Amendola, Naipy Perez, Victoria Vera, Miguel Montijano, Marco Amendola Tags: Skin ePoster Source Type: research
More News: Basal Cell Carcinoma | Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer | Squamous Cell Carcinoma | USA Health